Sunshine Biopharma (Sunshine Biopharma) Pre-Tax Income : $-3.72 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Sunshine Biopharma's pretax income for the three months ended in Mar. 2024 was $-1.26 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.72 Mil. Sunshine Biopharma's pretax margin was -16.72%.

During the past 13 years, Sunshine Biopharma's highest Pretax Margin was -13.90%. The lowest was -82650.00%. And the median was -4527.23%.

Sunshine Biopharma Pre-Tax Income Historical Data

The historical data trend for Sunshine Biopharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Biopharma Pre-Tax Income Chart

Sunshine Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-1.08

-2.78

-12.44

-26.51

-4.11

Sunshine Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-1.66	-0.81	-0.61	-1.03	-1.26

Competitive Comparison of Sunshine Biopharma's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Biopharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunshine Biopharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunshine Biopharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Sunshine Biopharma's Pre-Tax Income falls into.

Sunshine Biopharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Sunshine Biopharma's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.785	+	0	+	-0.137	+	0.812	+	-0.00099999999999945
	=	-4.11

Sunshine Biopharma's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.351	+	-0.006	+	-0.049	+	0.144	+	0.0010000000000001
	=	-1.26

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.72 Mil.

Sunshine Biopharma (NAS:SBFMW) Pre-Tax Income Explanation

Sunshine Biopharma's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.261	/	7.541
	=	-16.72%

During the past 13 years, Sunshine Biopharma's highest Pretax Margin was -13.90%. The lowest was -82650.00%. And the median was -4527.23%.

Sunshine Biopharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Biopharma (Sunshine Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

SBFM:USA

Address

6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5

Website

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).